ProShare Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-21,195
| Closed | -$96K | – | 1818 |
|
|
2017
Q3 | $96K | Buy |
21,195
+1,883
| +10% | +$8.53K | ﹤0.01% | 1329 |
|
|
2017
Q2 | $64K | Sell |
19,312
-2,928
| -13% | -$9.7K | ﹤0.01% | 1414 |
|
|
2017
Q1 | $205K | Sell |
22,240
-5,673
| -20% | -$52.3K | ﹤0.01% | 1444 |
|
|
2016
Q4 | $215K | Buy |
27,913
+2,518
| +10% | +$19.4K | ﹤0.01% | 1560 |
|
|
2016
Q3 | $290K | Buy |
25,395
+700
| +3% | +$7.99K | ﹤0.01% | 1166 |
|
|
2016
Q2 | $304K | Buy |
24,695
+338
| +1% | +$4.16K | ﹤0.01% | 1204 |
|
|
2016
Q1 | $246K | Sell |
24,357
-2,320
| -9% | -$23.4K | ﹤0.01% | 1306 |
|
|
2015
Q4 | $601K | Buy |
26,677
+2,134
| +9% | +$48.1K | 0.01% | 957 |
|
|
2015
Q3 | $407K | Sell |
24,543
-1,576
| -6% | -$26.1K | 0.01% | 1003 |
|
|
2015
Q2 | $588K | Sell |
26,119
-359
| -1% | -$8.08K | 0.01% | 1027 |
|
|
2015
Q1 | $683K | Buy |
26,478
+4,005
| +18% | +$103K | 0.01% | 1033 |
|
|
2014
Q4 | $489K | Buy |
22,473
+2,114
| +10% | +$46K | 0.01% | 1206 |
|
|
2014
Q3 | $385K | Sell |
20,359
-3,741
| -16% | -$70.7K | 0.01% | 1566 |
|
|
2014
Q2 | $562K | Sell |
24,100
-3,162
| -12% | -$73.7K | 0.01% | 1518 |
|
|
2014
Q1 | $917K | Buy |
27,262
+14,684
| +117% | +$494K | 0.01% | 1378 |
|
|
2013
Q4 | $371K | Buy |
+12,578
| New | +$371K | 0.01% | 1114 |
|